Rezolute Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Selling, General & Admin	27.48	18.37	14.68	12.18	9.36	7.91
Research & Development	74.12	61.53	55.74	43.81	32.49	14.99
Total Operating Expenses	101.6	79.89	70.42	55.99	41.84	22.89
Operating Income	-131.29	-79.89	-70.42	-55.99	-41.84	-22.89
Interest Income	5.77	5.48	4.87	4.21	0.08	0.06
Interest Expense	-	-	-	-	-1.81	-0.38
Other Non-Operating Income (Expense)	-0.02	-	-2.91	-0.01	2.51	2.3
Total Non-Operating Income (Expense)	5.75	5.48	1.96	4.2	0.78	1.99
Pretax Income	-125.54	-74.41	-68.46	-51.79	-41.06	-20.9
Net Income	-104.26	-74.41	-68.46	-51.79	-41.06	-20.9
Net Income to Common	-104.26	-74.41	-68.46	-51.79	-41.06	-20.9
Shares Outstanding (Basic)	101	76	51	51	18	8
Shares Outstanding (Diluted)	101	76	51	51	19	8
Shares Change (YoY)	54.80%	47.67%	0.55%	162.67%	154.04%	33.38%
EPS (Basic)	-0.82	-0.98	-1.33	-1.01	-2.26	-2.72
EPS (Diluted)	-0.82	-0.98	-1.33	-1.01	-2.32	-2.72
Shares Outstanding	96.29	87	53.25	36.83	33.58	8.35
Free Cash Flow	-73.48	-69.08	-57.37	-44.63	-39.62	-20.44
Free Cash Flow Per Share	-0.72	-0.91	-1.11	-0.87	-2.03	-2.66
EBITDA	-131.26	-79.86	-70.39	-55.96	-41.83	-22.88
EBIT	-131.29	-79.89	-70.42	-55.99	-41.84	-22.89

SEC Filings: 10-K · 10-Q